-
Mashup Score: 3New Insights into Biologic Therapies for BP - 4 day(s) ago
Complete remission was achieved in over 87% of dupilumab users and 64% of omalizumab users.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
📚 A new real-world study shows #dupilumab may outperform #omalizumab in treating bullous pemphigoid, offering faster control, higher remission, and fewer relapses, especially in complex cases. https://t.co/juCgGQ5FtI #BullousPemphigoid #BP #DermTwitter